Effect of AF, olaparib and aurola treatment on immune-related

Challenges and Opportunities for Childhood Cancer Drug Development

Christophe DEBEN, PostDoc Position, PhD

Immune checkpoint blockade and its combination therapy with small-molecule inhibitors for cancer treatment - ScienceDirect

Non‐coding RNA‐associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma - Khashkhashi Moghadam - 2022 - Journal of Cellular and Molecular Medicine - Wiley Online Library

The intracellular gold concentration levels caused by the

Frontiers Toxicities of Immunotherapy for Small Cell Lung Cancer

Marlies VERSCHUUREN, PhD Student

Induction of cell cycle arrest and apoptosis by ATL and olaparib. a, b

Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa

PDF) Auranofin Synergizes with the PARP Inhibitor Olaparib to

The intracellular gold concentration levels caused by the

Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review - ScienceDirect